FDA
-
-
-
-
-
-
-
Medicus Pharma Marks Nasdaq Anniversary With Opening Bell Ceremony
-
-
-
-
-
-
-
Medicus Pharma Ltd. to Present at Biotech Showcase 2026 as SkinJect Phase 2 Clinical Data Approaches Readout and Partnering Readiness Accelerates
-
-
-
-
-
-
-
Medicus Pharma names Carolyn Bonner CFO alongside president role
-
-
-
-
-
-
-
Medicus Pharma files for FDA priority voucher for skin cancer treatment
-
-
-
-
-
-
-
Medicus Pharma Ltd. Announces Collaboration with the Gorlin Syndrome Alliance to Pursue Compassionate Use Pathway for Skinject(TM) in Patients with Gorlin Syndrome
-
-
-
-
-
-
-
Medicus Pharma Ltd. to Present at the Family Office Summit in Dubai, UAE
-
-
-
-
-
-
-
Medicus Pharma Ltd. Provides Update on United Arab Emirates (UAE) SKNJCT-004 Phase 2 Clinical Study to Non-Invasively Treat Basal Cell Carcinoma of the Skin (BCC)
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

